Name | CB1 inverse agonist 1 |
---|
Description | CB1 inverse agonist 1 is a highly potent, orally active, and specific inverse agonist of CB1 receptor with IC50s of 7.5 nM and 4100 nM for CB1 and CB2 receptors, respectively. Anorexigenic effects[1]. |
---|---|
Related Catalog | |
Target |
CB1:7.5 nM (IC50) CB2:4100 nM (IC50) |
In Vivo | CB1 inverse agonist 1 (Compound 14; 0.3, 1, or 3 mg/kg)inhibits feeding in a dose-dependent manner[1]. The pharmacokinetic profile of CB1 inverse agonist 1 is evaluated in Sprague-Dawley rats, C57BL/6 mice, beagles, and rhesus macaques with t1/2 of >8, >8, >24, and 22 h, respectively[1]. Animal Model: Rat[1] Dosage: 0.3, 1, or 3 mg/kg Administration: PO Result: Inhibited feeding in a dose-dependent manner. 3 mg/kg decreased cumulative food intake from 2 h post-dosing. Decreased overnight body weight gain compared to vehicle treatment at all dosing levels. |
References |
Molecular Formula | C25H18Cl3N3O3 |
---|---|
Molecular Weight | 514.79 |